Hearing Aids Market

Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Hearing Loss (Sensorineural, Conductive), Patient Type (Adults, Pediatrics), Region - Global Forecast to 2026

Report Code: MD 3864 Jul, 2021, by marketsandmarkets.com

[238 Pages Report] The global hearing aids market is projected to reach USD 10.2 billion by 2026 from USD 7.5 billion in 2021, at a CAGR of 6.4%. Hearing aids market growth is driven by the technological advancements in hearing aids, growing prevalence of hearing loss, and the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss.

Hearing Aids Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Hearing Aids Market

The emergence of the COVID-19 pandemic has changed the delivery of medical care across the world. The increased pressure due to the growing rate of hospitalization of COVID-19 patients had led to the re-profiling of many hospitals and departments for treating patients with COVID-19. Consequently, many elective surgeries were canceled or postponed worldwide to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) toward COVID-19 patient care.

In particular, the provision of ENT-related surgeries and services has been disproportionally affected due to the reallocation of intensive care resources. According to the Centers for Disease Control and Prevention (CDC), ENT clinics and audiology centers pose a medium-to-high risk for COVID-19 infection, considering the proximity, test set-up, and length of appointments. The fact that a majority of people who require audiology services (aged over 65 years) are also the ones at the highest risk of COVID-19 related mortality and morbidity, underscores the importance of reassessing how hearing care is delivered.

The outbreak of COVID-19 has led to an increase in the preference for remote monitoring. The crisis has ushered in a new era in the hearing healthcare space that requires a radical rethinking of service delivery in audiology. Low- and no-touch services are now necessary for audiology patients (who are typically at the highest risk for COVID-19 morbidity and mortality due to their advanced age). Also, hearing aid manufacturers have started focusing on including mobile audiometry and digital hearing care solutions for remote hearing aid device troubleshooting, counseling, fine-tuning, and tracking.

Market Dynamics

Driver:  Growing prevalence of hearing loss

Globally, the rising incidence of hearing loss has made it extremely important to monitor and examine hearing functions. In children, untreated hearing loss negatively impacts language development, learning, and social engagement. Similarly, older adults with hearing loss often have difficulty following day-to-day conversations. For people entering their retirement years, untreated hearing loss has been linked to several physical and psychological issues, ranging from cognitive decline and depression to an increased risk of trips and falls.

Opportunity: Emerging markets offer lucrative opportunities

Emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the hearing aids market to focus on emerging countries.

Restraint: High cost of hearing aids

The high cost of hearing aids, such as cochlear implants and bone-anchored systems, is a major factor restraining the market growth, particularly in price-sensitive regions such as the Asia Pacific, Latin America, and Africa. Healthcare providers, especially in developing countries such as Brazil and Mexico, have low financial resources to invest in sophisticated technologies. Moreover, the staff must be extensively trained for the efficient handling and maintenance of cochlear implants and bone-anchored systems. Extensive R&D activities are required to develop technologically advanced hearing aids. This results in a significant increase in the cost of manufacturing and the end price for customers. This makes associated surgical interventional procedures and diagnostic tests correspondingly expensive for patients.

Challenge: Shortage of trained professionals

Currently, several countries are facing a shortage of skilled professionals who are capable of effectively performing ENT procedures, such as cochlear implantation. Underdeveloped countries and regions face this problem on a much wider scale. The dearth of skilled ENT surgeons in these countries is expected to limit the number of ENT procedures performed, including cochlear implantation, carried out per year despite the presence of a large target patient population base. This is a major challenge for the growth of the hearing aids market.

In 2020, hearing aid devices accounted for the largest share of the hearing aids market, by product

The hearing aids market is segmented into hearing aid devices and hearing implants based on product. The hearing aid devices segment accounted for the largest share of the hearing aids market in 2020, mainly due to the increasing technological advancements in hearing aid devices and the increasing number of product approvals.

In 2020, sensorineural hearing loss segment accounted for the largest share in the market, by type of hearing loss

The hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss based on type of hearing loss. In 2020, the sensorineural hearing loss segment accounted for the largest share. Factors such as the high prevalence of sensorineural hearing loss, coupled with the growing geriatric patient pool and an increase in the number of product approvals are driving the growth of this segment.

In 2020, adult patients segment accounted for the largest share in the market, by patient type

The hearing aids market is segmented into adults and pediatrics based on patient type. In 2020, the adult patients segment accounted for the largest share of the hearing aids market. The growing incidence of hearing loss among the adult population is driving the growth of this segment.

Europe is the largest regional market for hearing aids

The global hearing aids market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, Europe accounted for the largest share of the hearing aids market.  The European hearing aids market’s growth can be attributed to the well-established healthcare industry, the increasing incidence of hearing disorders, and the rapid adoption of technologically advanced hearing aids.

Hearing Aids Market by Region

Some key players in the hearing aids market (2021- 2026)

  • Sonova Group (Switzerland)
  • Demant A/S (Denmark)
  • GN Store Nord A/S (Denmark)
  • Cochlear Ltd. (Australia)
  • RION Co., Ltd. (Japan)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2016–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, type of hearing loss, patient type, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Sonova Group (Switzerland), Demant A/S (Denmark), GN Store Nord A/S (Denmark), Cochlear Ltd. (Australia), RION Co., Ltd. (Japan), Starkey (US), Nurotron Biotechnology Co., Ltd. (China), MED-EL (Austria), Audina Hearing Instruments, Inc. (US), Elkon Pvt. Ltd. (India), WS Audiology A/S (Denmark), Eargo, Inc. (US), Horentek (Italy), ZOUNDS Hearing Inc. (US), SeboTek Hearing Systems, LLC. (US), Arphi Electronics Private Limited (India), IN4 Technology Corporation (China), BHM-Tech Produktionsgesellschaft mbH (Austria), Nano Hearing Aids (US), LORECa s.r.o. (Turkey), Earlens Corporation (US), Austar Hearing Science and Technology (Xiamen) Co., Ltd. (China), Lively Hearing Corporation (US), audifon GmbH & Co. KG (Germany), and Foshan Vohom Technology Co., Ltd. (China)

This report categorizes the hearing aids market into the following segments and subsegments:

By Product

  • Hearing Aid Devices
    • Receiver-in-the-ear Hearing Aids
    • Behind-the-ear Hearing Aids
    • Canal Hearing Aids
    • In-the-ear Hearing Aids
    • Other Hearing Aid Devices
  • Hearing Implants
    • Cochlear Implants
    • Bone-anchored Systems

By Type of Hearing Loss

  • Sensorineural Hearing Loss
  • Conductive Hearing Loss

By Patient Type

  • Adults
  • Pediatrics

By Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In February 2021, GN Hearing (Denmark) launched ReSound Key, a hearing aid line-up that provides greater access to its proven and award-winning hearing technology worldwide.
  • In October 2020, Starkey (US) partnered with OrCam Technologies (Israel) to provide assistive technologies to hearing and visually impaired people. This partnership enhanced OrCam’s ability to apply the advanced computer vision and machine learning methods that they had developed to transmit the visual world through audio, in collaboration with Starkey’s Livio Edge AI hearing aids.
  • In July 2020, Cochlear Ltd. (Australia) received US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and Custom Sound Pro fitting software.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
                    FIGURE 1 HEARING AIDS MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
           FIGURE 2 HEARING AIDS MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Primary sources
                    2.2.2.2 Key data from primary sources
                    2.2.2.3 Key industry insights
                    2.2.2.4 Breakdown of primary interviews
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET)
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                               FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.3.1.2 Approach 2: Market estimation from the parent market
                               FIGURE 6 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET
                    2.3.1.3 Approach 3: Presentations of companies and primary interviews
                    2.3.1.4 Growth rate assumptions
                    2.3.1.5 CAGR projections
                               FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 8 HEARING AIDS MARKET: TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 LIMITATIONS
    2.7 RISK ASSESSMENT
           TABLE 1 RISKS ASSESSMENT
    2.8 COVID-19 HEALTH ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
           FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET

3 EXECUTIVE SUMMARY (Page No. - 49)
    FIGURE 11 HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 HEARING AIDS MARKET OVERVIEW
           FIGURE 15 RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH
    4.2 HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 2026
           FIGURE 16 HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
    4.3 HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 2026
           FIGURE 17 SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    4.4 HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 2026
           FIGURE 18 ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026
    4.5 HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 20 HEARING AIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing prevalence of hearing loss
                               FIGURE 21 ESTIMATED NUMBER OF PEOPLE WITH DISABLING HEARING LOSS, GLOBALLY
                               FIGURE 22 PREVALENCE OF HEARING LOSS, BY REGION, 2019
                               5.2.1.1.1 Growth in the geriatric population
                                            FIGURE 23 SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019)
                    5.2.1.2 Technological advancements in hearing aids
                    5.2.1.3 Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of hearing aids
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets offer lucrative opportunities
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of trained professionals
    5.3 EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF HEARING AID DEVICES
           TABLE 2 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP
           TABLE 3 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)
           TABLE 4 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP
    5.4 IMPACT OF COVID-19 ON THE HEARING AIDS MARKET
    5.5 CASE STUDY ANALYSIS
           5.5.1 CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS
           5.5.2 CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS
           5.5.3 CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY
    5.6 PESSIMISTIC AND OPTIMISTIC SCENARIOS
           5.6.1 HEARING AIDS MARKET
                    FIGURE 24 PESSIMISTIC SCENARIO
                    FIGURE 25 OPTIMISTIC SCENARIO
    5.7 PRICING ANALYSIS
           TABLE 5 PRICE OF HEARING AIDS (2021)
    5.8 PATENT ANALYSIS
           5.8.1 PATENT ANALYSIS OF COCHLEAR IMPLANTS
    5.9 TRADE ANALYSIS
           5.9.1 TRADE ANALYSIS FOR HEARING AIDS
                    TABLE 6 IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)
                    TABLE 7 EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)
    5.10 VALUE CHAIN ANALYSIS
           FIGURE 26 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
           5.10.1 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR
                     TABLE 8 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR
    5.11 SUPPLY CHAIN ANALYSIS
           FIGURE 27 HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS
    5.12 ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET
           FIGURE 28 HEARING AIDS MARKET: ECOSYSTEM ANALYSIS
           5.12.1 ROLE IN ECOSYSTEM
    5.13 PORTER’S FIVE FORCES ANALYSIS
           TABLE 9 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 BARGAINING POWER OF SUPPLIERS
           5.13.5 DEGREE OF COMPETITION
    5.14 REGULATORY LANDSCAPE
           5.14.1 NORTH AMERICA
                    5.14.1.1 US
                    5.14.1.2 Canada
           5.14.2 EUROPE
           5.14.3 ASIA PACIFIC
                    5.14.3.1 Japan
                    5.14.3.2 India
           5.14.4 LATIN AMERICA
                    5.14.4.1 Brazil
                    5.14.4.2 Mexico
           5.14.5 MIDDLE EAST
    5.15 TECHNOLOGY ANALYSIS
    5.16 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
           5.16.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
           5.16.2 REVENUE SHIFT FOR THE HEARING AIDS MARKET

6 HEARING AIDS MARKET, BY PRODUCT (Page No. - 75)
    6.1 INTRODUCTION
           TABLE 10 HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 11 HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
    6.2 HEARING AID DEVICES
           TABLE 12 KEY PRODUCTS IN THE HEARING AID DEVICES MARKET
           TABLE 13 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 14 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)
           TABLE 15 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (MILLION UNITS)
           TABLE 16 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (MILLION UNITS)
           TABLE 17 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)
           TABLE 18 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)
           TABLE 19 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)
           TABLE 20 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)
           TABLE 21 APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (MILLION UNITS)
           TABLE 22 APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (MILLION UNITS)
           TABLE 23 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 24 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION)
           TABLE 25 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (MILLION UNITS)
           TABLE 26 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (MILLION UNITS)
           6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS
                    6.2.1.1 RITE hearing aid devices are suitable for the treatment of mild-to-severe hearing loss
                               TABLE 27 KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET
                               TABLE 28 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 29 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 30 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 31 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 32 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 33 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 34 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 35 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           6.2.2 BEHIND-THE-EAR HEARING AIDS
                    6.2.2.1 Low cost of BTE devices to support the market growth
                               TABLE 36 KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET
                               TABLE 37 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 38 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 39 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 40 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 41 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 42 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 43 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 44 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           6.2.3 CANAL HEARING AIDS
                    6.2.3.1 Technological advancements in canal hearing aids to propel market growth
                               TABLE 45 KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET
                               TABLE 46 CANAL HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 47 CANAL HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 48 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 49 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 50 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 51 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 52 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 53 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           6.2.4 IN-THE-EAR HEARING AIDS
                    6.2.4.1 Longer battery life of ITE hearing devices to support the market growth
                               TABLE 54 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 55 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 56 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 57 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 58 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 59 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 60 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 61 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           6.2.5 OTHER HEARING AID DEVICES
                    TABLE 62 OTHER HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 63 OTHER HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)
                    TABLE 64 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                    TABLE 65 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                    TABLE 66 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                    TABLE 67 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                    TABLE 68 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                    TABLE 69 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
    6.3 HEARING IMPLANTS
           TABLE 70 HEARING IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 71 HEARING IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)
           TABLE 72 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 73 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 74 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 75 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 76 APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 77 APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 78 HEARING IMPLANTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
           TABLE 79 HEARING IMPLANTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
           6.3.1 COCHLEAR IMPLANTS
                    6.3.1.1 Cochlear implants segment to dominate the hearing implants market
                               TABLE 80 KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET
                               TABLE 81 COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 82 COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 83 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 84 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 85 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 86 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 87 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 88 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           6.3.2 BONE-ANCHORED SYSTEMS
                    6.3.2.1 BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss
                               TABLE 89 BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2016–2019 (USD MILLION)
                               TABLE 90 BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2020–2026 (USD MILLION)
                               TABLE 91 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 92 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 93 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 94 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                               TABLE 95 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                               TABLE 96 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)

7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS (Page No. - 115)
    7.1 INTRODUCTION
           TABLE 97 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
           TABLE 98 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
    7.2 SENSORINEURAL HEARING LOSS
           7.2.1 GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
                    7.2.1.1 Primary notes
                               7.2.1.1.1 Key industry insights
                                            TABLE 99 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)
                                            TABLE 100 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)
    7.3 CONDUCTIVE HEARING LOSS
           7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH
                    TABLE 101 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 102 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)

8 HEARING AIDS MARKET, BY PATIENT TYPE (Page No. - 120)
    8.1 INTRODUCTION
           TABLE 103 HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
           TABLE 104 HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
    8.2 ADULTS
           8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL
                    8.2.1.1 Primary notes
                               8.2.1.1.1 Key industry insights
                                            TABLE 105 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2016–2019 (USD MILLION)
                                            TABLE 106 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2020–2026 (USD MILLION)
    8.3 PEDIATRICS
           8.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 107 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 108 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020–2026 (USD MILLION)

9 HEARING AIDS MARKET, BY REGION (Page No. - 126)
    9.1 INTRODUCTION
           TABLE 109 HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)
           TABLE 110 HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)
    9.2 EUROPE
           FIGURE 29 EUROPE: HEARING AIDS MARKET SNAPSHOT
           TABLE 111 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 112 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 113 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 114 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 115 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
           TABLE 116 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
           9.2.1 GERMANY
                    9.2.1.1 Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids
                               FIGURE 30 PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018
                               FIGURE 31 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018
                               TABLE 117 GERMANY: KEY MACROINDICATORS
                               TABLE 118 GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 119 GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 120 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 121 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 122 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 123 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.2.2 UK
                    9.2.2.1 High and growing prevalence of hearing loss to drive market growth in the UK
                               TABLE 124 UK: KEY MACROINDICATORS
                               TABLE 125 UK: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 126 UK: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 127 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 128 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 129 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 130 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.2.3 FRANCE
                    9.2.3.1 Rising R&D expenditure in France to drive the market growth
                               FIGURE 32 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018
                               TABLE 131 FRANCE: KEY MACROINDICATORS
                               TABLE 132 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 133 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 134 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 135 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 136 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 137 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.2.4 SPAIN
                    9.2.4.1 Increasing life expectancy and growing geriatric population to drive market growth in Spain
           FIGURE 33 SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP
                               TABLE 138 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 139 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 140 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 141 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 142 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 143 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.2.5 ITALY
                    9.2.5.1 Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent
                               FIGURE 34 PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018
                               FIGURE 35 HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018
                               TABLE 144 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 145 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 146 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 147 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 148 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 149 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.2.6 REST OF EUROPE
                    TABLE 150 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
                    TABLE 151 ROE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 152 ROE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 153 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                    TABLE 154 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                    TABLE 155 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                    TABLE 156 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
    9.3 NORTH AMERICA
           TABLE 157 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
           TABLE 158 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
           TABLE 159 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
           TABLE 160 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
           TABLE 161 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
           TABLE 162 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
           9.3.1 US
                    9.3.1.1 The US dominated the North American hearing aids market in 2020
                               FIGURE 36 NUMBER OF AUDIOLOGISTS IN THE US
                               TABLE 163 US: KEY MACROINDICATORS
                               TABLE 164 US: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 165 US: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 166 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 167 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 168 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 169 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.3.2 CANADA
                    9.3.2.1 Conferences, webinars, and symposia to provide impetus to the market growth
                               TABLE 170 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 171 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 172 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 173 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 174 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 175 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
    9.4 ASIA PACIFIC
                    FIGURE 37 ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT
                    TABLE 176 APAC: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                    TABLE 177 APAC: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
                    TABLE 178 APAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 179 APAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 180 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                    TABLE 181 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China dominated the APAC market for hearing aids in 2020
                               TABLE 182 CHINA: KEY MACROINDICATORS
                               TABLE 183 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 184 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 185 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 186 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 187 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 188 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.4.2 INDIA
                    9.4.2.1 Healthcare infrastructure improvements to drive market growth in India
                               TABLE 189 INDIA: KEY MACROINDICATORS
                               TABLE 190 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 191 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 192 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 193 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 194 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 195 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Rising adoption of hearing aids in the country to support market growth
                               FIGURE 38 HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018
                               TABLE 196 JAPAN: KEY MACROINDICATORS
                               TABLE 197 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 198 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 199 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 200 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 201 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 202 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Rising geriatric population to drive market growth in Australia
                               FIGURE 39 DISTRIBUTIVE SHARE OF POPULATION IN AUSTRALIA, BY AGE GROUP, 2016 VS. 2019
                               TABLE 203 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                               TABLE 204 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                               TABLE 205 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                               TABLE 206 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                               TABLE 207 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                               TABLE 208 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    FIGURE 40 DISTRIBUTIVE SHARE OF POPULATION IN TAIWAN, BY AGE GROUP, 2016 VS. 2019
                    TABLE 209 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 210 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 211 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                    TABLE 212 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                    TABLE 213 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                    TABLE 214 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH
                    FIGURE 41 NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018
                    TABLE 215 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 216 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 217 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                    TABLE 218 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                    TABLE 219 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                    TABLE 220 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS IN THE REGION TO DRIVE MARKET GROWTH
                    TABLE 221 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
                    TABLE 222 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                    TABLE 223 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)
                    TABLE 224 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)
                    TABLE 225 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)
                    TABLE 226 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 182)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE HEARING AIDS MARKET
             TABLE 227 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEARING AIDS MANUFACTURING COMPANIES
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 42 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE HEARING AIDS MARKET
     10.4 MARKET SHARE ANALYSIS
             FIGURE 43 HEARING AIDS MARKET SHARE, BY KEY PLAYER (2020)
             TABLE 228 HEARING AIDS MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 LIST OF EVALUATED VENDORS
             10.5.2 STARS
             10.5.3 EMERGING LEADERS
             10.5.4 PERVASIVE PLAYERS
             10.5.5 PARTICIPANTS
                        FIGURE 44 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
     10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 45 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
     10.7 COMPETITIVE BENCHMARKING
             10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
                        FIGURE 46 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE HEARING AIDS MARKET
                        TABLE 229 PRODUCT FOOTPRINT OF COMPANIES
                        TABLE 230 REGIONAL FOOTPRINT OF COMPANIES
     10.8 COMPETITIVE SCENARIO
             10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
                        TABLE 231 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
             10.8.2 DEALS
                        TABLE 232 KEY DEALS

11 COMPANY PROFILES (Page No. - 194)
     11.1 KEY PLAYERS
     (Business Overview, Products Offered, Recent Developments, and MnM View)* 
             11.1.1 SONOVA GROUP
                        TABLE 233 SONOVA GROUP: BUSINESS OVERVIEW
                        FIGURE 47 SONOVA GROUP: COMPANY SNAPSHOT (2020)
             11.1.2 DEMANT A/S
                        TABLE 234 DEMANT A/S: BUSINESS OVERVIEW
                        FIGURE 48 DEMANT A/S: COMPANY SNAPSHOT (2020)
             11.1.3 GN STORE NORD A/S
                        TABLE 235 GN STORE NORD A/S: BUSINESS OVERVIEW
                        FIGURE 49 GN STORE NORD A/S: COMPANY SNAPSHOT (2020)
             11.1.4 COCHLEAR LTD.
                        TABLE 236 COCHLEAR LTD.: BUSINESS OVERVIEW
                        FIGURE 50 COCHLEAR LTD.: COMPANY SNAPSHOT (2020)
             11.1.5 RION CO., LTD.
                        TABLE 237 RION CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 51 RION CO., LTD.: COMPANY SNAPSHOT (2020)
             11.1.6 STARKEY
                        TABLE 238 STARKEY: BUSINESS OVERVIEW
             11.1.7 WS AUDIOLOGY A/S
                        TABLE 239 WS AUDIOLOGY A/S: BUSINESS OVERVIEW
             11.1.8 NUROTRON BIOTECHNOLOGY CO., LTD.
                        TABLE 240 NUROTRON BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
             11.1.9 MED-EL
                        TABLE 241 MED-EL: BUSINESS OVERVIEW
             11.1.10 AUDINA HEARING INSTRUMENTS, INC.
                        TABLE 242 AUDINA HEARING INSTRUMENTS, INC.: BUSINESS OVERVIEW
             11.1.11 ELKON PVT. LTD.
                        TABLE 243 ELKON PVT. LTD.: BUSINESS OVERVIEW
     * Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies. 
     11.2 OTHER PLAYERS
             11.2.1 EARGO, INC.
             11.2.2 HORENTEK
             11.2.3 ZOUNDS HEARING INC.
             11.2.4 SEBOTEK HEARING SYSTEMS, LLC.
             11.2.5 ARPHI ELECTRONICS PRIVATE LIMITED
             11.2.6 IN4 TECHNOLOGY CORPORATION
             11.2.7 BHM-TECH PRODUKTIONSGESELLSCHAFT MBH
             11.2.8 NANO HEARING AIDS
             11.2.9 LORECA S.R.O.
             11.2.10 EARLENS CORPORATION
             11.2.11 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD.
             11.2.12 LIVELY HEARING CORPORATION
             11.2.13 AUDIFON GMBH & CO. KG
             11.2.14 FOSHAN VOHOM TECHNOLOGY CO., LTD.

12 APPENDIX (Page No. - 232)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the hearing aids market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

Hearing Aids Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the hearing aids market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the hearing aids market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Hearing Aids Market Size: Top-Down Approach

Hearing Aids Market Size, and Top-Down Approach

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global hearing aids market by product, type of hearing loss, patient type, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall hearing aids market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze company developments such as product launches, regulatory approvals, agreements, partnerships, and acquisitions in the hearing aids market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Hearing aids market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa

Company profiles

  • Additional five company profiles of players operating in the hearing aids market
COVID-19

Get in-depth analysis of the COVID-19 impact on the Hearing Aids Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Hearing Aids Market

Request For Special Pricing
Report Code
MD 3864
Published ON
Jul, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hearing Aids Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved